Summary

Eligibility
for people ages 18-100 (full criteria)
Location
at San Francisco, California and other locations
Dates
study started
completion around

Description

Summary

Accurately predicting kidney recipient risk of death has a crucial interest because of the organ shortage, the need to optimize allograft allocation by identifying high-risk patients who may not benefit from a transplant and improve the clinical decision-making after transplant to ensure that each patient survives as long as possible.

However, according to a literature review the investigators performed, studies attempting to develop a kidney recipient death prediction model suffer from many shortcomings, including the lack of key risk factors, use of biased registry data, small sample size, lack of external validation in different countries and subpopulations, and short follow-up.

The present study thus aimed to address these limitations and develop a robust, generalizable kidney recipient death prediction model.

Official Title

Development and Validation of a Prediction Model for Risk of Death in Kidney Transplant Recipients

Details

Keywords

Death, Necker hospital from Paris, France, Saint-Louis hospital from Paris, France, Bichat hospital from Paris, France, Bretonneau hospital from Tours, France, Toulouse hospital, France, KU Leuven, Belgium, Liege hospital from Belgium, Hospital of the University of Pennsylvania from Philadelphia, US, Mayo Clinic from Phoenix, US, UCSF database, AP-HP database

Eligibility

You can join if…

Open to people ages 18-100

  • Adult kidney recipients

You CAN'T join if...

  • Multi-organ transplantation
  • Prior kidney transplant

Locations

  • Bakar Computational Health Sciences Institute, University of California
    San Francisco California 94158 United States
  • Department of Medicine, Mayo Clinic
    Phoenix Arizona 85054 United States

Details

Status
accepting new patients by invitation only
Start Date
Completion Date
(estimated)
Sponsor
Paris Translational Research Center for Organ Transplantation
ID
NCT06531967
Study Type
Observational
Participants
Expecting 13000 study participants
Last Updated